Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.3120
-0.0100 (-3.11%)
Last updated: Aug 3, 2026, 3:02 PM CET

EPA:ALOPM Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.260.211.077.98-
Revenue Growth
26.13%-80.69%-86.57%80.97%-
Cost of Revenue
---0.02-
Gross Profit
0.260.211.077.96-
Selling, General & Admin
6.189.1811.389.67-
Depreciation & Amortization Expenses
2.870.260.250.16-
Other Operating Expenses
0.050.010.060.08-
Total Operating Expenses
9.19.4411.699.910
Operating Income
5.71-7.81-9.94-1.61-
Interest Income
0.050.30.250-
Interest Expense
-0.19-0.44-0.15-0.12-
Other Non-Operating Income (Expense)
-0.04-0.02-0.01-0-
Total Non-Operating Income (Expense)
-0.18-0.150.09-0.11-
Pretax Income
5.53-7.96-9.85-1.72-
Provision for Income Taxes
0.03-1.1-1.76-1.49-
Net Income
5.5-6.86-8.09-0.23-
Net Income to Common
5.48-7.21-8.09-0.23-
Net Income Growth
-----
Shares Outstanding (Basic)
181817170
Shares Outstanding (Diluted)
181817170
Shares Change
-9.06%0.43%1660651.40%-
EPS (Basic)
0.30-0.40-0.49-0.01-
EPS (Diluted)
0.30-0.40-0.49-0.01-
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
0000-2.92
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-----2916.00
Gross Margin
100.00%100.00%100.00%99.80%-
Operating Margin
2185.54%-3770.81%-927.44%-20.17%-
Profit Margin
2105.49%-3313.36%-754.61%-2.90%-
EBITDA
5.71-7.81-9.94-1.610
EBIT
5.71-7.81-9.94-1.61-
EBIT Margin
2185.54%-3770.81%-927.44%-20.17%-
Effective Tax Rate
0.61%13.83%17.89%86.58%-